Measuring executive dysfunction in an acute rehabilitation setting: Using the dysexecutive questionnaire (DEX), Journal of the International Neuropsychological Society, vol.11, pp.376-385, 2005. ,
Confronting chemobrain: An in-depth look at survivors' reports of impact on work, social networks, and health care response, Journal of Cancer Survivorship, vol.3, pp.223-232, 2009. ,
Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment, Journal of Cancer Survivorship, vol.12, pp.537-559, 2018. ,
The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure, Journal of Clinical Oncology, vol.11, pp.570-579, 1993. ,
Neural correlates of metamemory: A comparison of feeling-of-knowing and retrospective confidence judgments, Journal of Cognitive Neuroscience, vol.21, pp.1751-1765, 2009. ,
Metamemory function in chemotherapy-treated patients with breast cancer: An explanation for the dissociation between subjective and objective memory measures?, Psychooncology, vol.26, pp.109-117, 2017. ,
Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests, Journal of Neurology, vol.266, 2019. ,
Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy, Journal of Cancer Survivorship, vol.12, pp.178-185, 2018. ,
The role of metacognitive experiences in the learning process, Psicothema, vol.21, pp.76-82, 2009. ,
Clinical evaluation of memory, Revue Neurologique, vol.154, pp.18-32, 1998. ,
Cognitive complaints after breast cancer treatments: Examining the relationship with neuropsychological test performance, Journal of the National Cancer Institute, vol.105, pp.791-801, 2013. ,
Two different sides of 'chemobrain': Determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study, Psycho-Oncology, vol.19, pp.1321-1328, 2010. ,
A meta-analysis of the effects of chemotherapy on cognition in patients with cancer, Cancer Treatment Reviews, vol.39, pp.297-304, 2013. ,
Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review, Cancer Treatment Reviews, vol.38, pp.926-934, 2012. ,
Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: An analysis from a Nationwide, Multicenter. Prospective Longitudinal Study, Journal of Clinical Oncology, vol.35, pp.506-514, 2017. ,
Impact of cancer and its treatments on cognitive function: Advances in research from the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012, Journal of Pain and Symptom Management, vol.50, pp.830-841, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02280712
French version of the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) version 3. Supportive Care in Cancer, vol.20, pp.3297-3305, 2012. ,
Delaying judgments of learning affects memory, not metamemory, Memory & Cognition, vol.31, pp.918-929, 2003. ,
Illusions of competence in monitoring one's knowledge during study, Journal of Experimental Psychology. Learning, Memory, and Cognition, vol.31, pp.187-194, 2005. ,
How to identify and manage cognitive dysfunction after breast cancer treatment, Journal of Oncology Practice, vol.13, pp.784-790, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02094003
Study of metamemory in patients with chronic alcoholism using a feeling-of-knowing episodic memory task. Alcoholism, Clinical and Experimental Research, vol.34, pp.1888-1898, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00538645
Emotional specificities of autobiographical memory after breast cancer diagnosis, Consciousness and Cognition, vol.35, pp.42-52, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01226417
Metamemory: A theoretical framework and new findings, The psychology of learning and motivation: Advances in research and theory, pp.125-173, 1990. ,
Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian Breast Cancer Survivors, Psychooncology, vol.27, pp.1185-1192, 2018. ,
Monitoring processes and metamemory experience in patients with dysexecutive syndrome, Brain and Cognition, vol.57, pp.185-188, 2005. ,
Subjective cognitive dysfunction in breast cancer patients: A systematic review, Psycho-Oncology, vol.19, pp.1127-1138, 2010. ,
The CES-D Scale: A self-report depression scale for research in the general population, Applied Psychological Measurement, vol.1, pp.385-401, 1977. ,
Validity of trail making tests as an indicator of organic brain damage, Perceptual & Motor Skills, vol.8, pp.271-276, 1958. ,
Learning and memory performance in breast cancer survivors 2 to 6 years post-treatment: The role of encoding versus forgetting, Journal of Cancer Survivorship, vol.10, pp.593-599, 2016. ,
Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients, Psycho-Oncology, vol.21, pp.1132-1135, 2012. ,
Manual for the State-Trait Anxiety Inventory (STAI), 1983. ,
Studies of interference in serial verbal reactions, Journal of Experimental Psychology, 1935. ,
A memory self-report questionnaire (QAM), 1989. ,
Measuring patient self-reported cognitive function: Development of the functional assessment of cancer therapy-cognitive function instrument, The Journal of Supportive Oncology, vol.7, pp.32-39, 2009. ,
International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, The Lancet Oncology, vol.12, issue.10, pp.70294-70295, 2011. ,
The feasibility of using metacognitive strategy training to improve cognitive performance and neural connectivity in women with chemotherapy-induced cognitive impairment, Oncology, vol.91, pp.143-152, 2016. ,
Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system, Journal of Pain and Symptom Management, vol.13, pp.274-280, 1997. ,